|
Kagamu, H; Shu, S (1998) Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes. J Immunol 160:3444-52
|
|
Liu, J; Finke, J; Krauss, J C et al. (1998) Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules. Cancer Immunol Immunother 46:268-76
|
|
Plautz, G E; Touhalisky, J E; Shu, S (1997) Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells. Cell Immunol 178:101-7
|
|
Kagamu, H; Touhalisky, J E; Plautz, G E et al. (1996) Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes. Cancer Res 56:4338-42
|
|
Inoue, M; Plautz, G E; Shu, S (1996) Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells. Cancer Res 56:4702-8
|
|
Krauss, J C; Stein, J M; Shu, S (1996) Tumor reactivity of immune T cells in short-term culture. Cancer Immunol Immunother 43:231-9
|
|
Plautz, G E; Inoue, M; Shu, S (1996) Defining the synergistic effects of irradiation and T-cell immunotherapy for murine intracranial tumors. Cell Immunol 171:277-84
|
|
Sussman, J J; Wahl, W L; Chang, A E et al. (1995) Unique characteristics associated with systemic adoptive immunotherapy of experimental intracerebral tumors. J Immunother Emphasis Tumor Immunol 18:35-44
|
|
Aruga, A; Shu, S; Chang, A E (1995) Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells. Cancer Immunol Immunother 41:317-24
|
|
Matsumura, T; Sussman, J J; Krinock, R A et al. (1994) Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes. Cancer Res 54:2744-50
|
Showing the most recent 10 out of 12 publications
